Gut Health After Menopause: What the Microbiome Research Shows

What actually happens to gut bacteria after menopause?

In 2022, researchers published a large analysis in the journal mSystems using the Hispanic Community Health Study/Study of Latinos, a long-running health cohort. They ran full genetic sequencing on stool samples from 295 premenopausal women, 1,027 postmenopausal women, and 978 men, making it one of the largest human studies of its kind.

The findings were specific. Postmenopausal women showed significantly lower gut bacteria diversity than premenopausal women, and their overall bacterial composition had shifted to resemble men's gut bacteria more closely than premenopausal women's did. Postmenopausal women also carried a higher relative abundance of Bacteroides, a major gut bacteria group.

A few things are worth stating plainly about what this proves.

What this study does and does not prove

• It is a large, real human cohort, not an animal study, which makes it unusually strong evidence for this specific claim
• It shows an association between menopausal status and gut bacteria changes, adjusted for age and other factors, not a single isolated cause
• It separately found these gut bacteria shifts were linked to worse cardiometabolic risk markers, which is a meaningful downstream connection
• It did not test any intervention. It describes what happens, not what reverses it

What is the estrobolome, and why does it matter?

The research community has a specific term for this. They call it the estrobolome, the two-way relationship between estrogen and gut bacteria. It refers to the collection of gut bacteria genes capable of producing an enzyme called beta-glucuronidase.

Here is the mechanism in plain terms. The liver processes used estrogen and tags it for removal from the body. Certain gut bacteria, carrying that beta-glucuronidase enzyme, can untag that estrogen and let it be reabsorbed back into circulation instead of excreted. That means your gut bacteria composition genuinely influences how much of your own remaining estrogen gets recycled rather than lost.

Here is why that matters over time.

Why this can become a cycle worth understanding

1. As estrogen production declines during menopause, the gut bacteria populations that respond to estrogen signaling shift too
2. A lower-diversity gut bacteria population, the kind the 2022 study found in postmenopausal women, may recycle less of the estrogen that is still being produced
3. That is a plausible two-way loop, not a proven one. Researchers describe it as an active area of study, not a settled mechanism
4. It is also why gut health research gets raised alongside menopause research at all. It is not a stretch connection

Why does this connect to cardiometabolic health specifically?

The 2022 cohort study did not stop at describing the bacterial shift. The researchers also tested whether that shift connected to measurable health markers, and it did.

Postmenopausal women's altered gut bacteria composition was independently associated with worse cardiometabolic risk markers, the kind of blood sugar, lipid, and inflammation measures doctors track for heart disease and diabetes risk. That association held even after the researchers adjusted for age, meaning menopausal status itself, not just getting older, tracked with the pattern.

Why gut bacteria would connect to metabolic health at all

• Gut bacteria produce short-chain fatty acids from fiber, which influence how the body regulates blood sugar and inflammation
• A less diverse bacterial population generally means fewer different metabolic byproducts being produced, narrowing that influence
• The estrobolome connection above means bacterial shifts can also affect circulating estrogen, which itself influences cardiometabolic risk independently
• Researchers describe this as a web of connected systems, not a single bacterium causing a single disease

What does the shilajit-related research on gut bacteria show?

No trial has tested shilajit itself against gut bacteria in postmenopausal women. The closest real evidence is for humic acid, one of the organic compounds found inside shilajit resin.

A 2017 study published in the World Journal of Gastroenterology gave 14 healthy volunteers an oral humic acid supplement for 45 days and tracked their stool bacteria using a fluorescence lab technique. The results were specific. Overall bacterial concentration rose 14% in the main established bacterial groups, 28% in smaller pioneer groups, and 41% in a third category the researchers tracked separately, by day 45. The researchers specifically noted this grew bacteria broadly rather than wiping out diversity the way some interventions can.

A few limits are worth stating plainly here too.

The honest limits of this evidence

• It is a small study, 14 volunteers, and it tested humic acid specifically, not whole shilajit resin
• The increase in Bifidobacteria specifically, a group researchers often highlight for digestive health, was not statistically significant in this particular study, even though overall bacterial growth was
• None of the volunteers were described as postmenopausal, so this study cannot speak directly to the menopause-specific diversity loss described above
• What it does show is that a compound found in shilajit has measurable, human-tested effects on gut bacteria growth, which is a reasonable starting point for the question, not an answer to it

How does that compare to other gut-bacteria research?

The table is here to be honest about the gap, not to oversell the connection. The menopause-specific diversity finding and the humic acid finding are two separate, real pieces of research that have not yet been tested together.

What actually supports gut bacteria diversity?

Independent of the shilajit question, the broader gut bacteria research base points to a few consistent, evidence-backed habits:

• Eating a wide variety of plant foods, not just more fiber in general, is the factor most consistently tied to higher bacterial diversity across human studies
• Fermented foods have measurably shifted gut bacteria composition in controlled human trials, separate from supplement research
• Specific, well-studied probiotic strains have reduced digestive symptoms like bloating and cramping in randomized trials of hundreds of patients, though strain matters, since not all probiotics are interchangeable
• Limiting unnecessary antibiotic use, when medically appropriate to do so, protects the bacterial diversity those other habits are working to build

See Optimum Shilajit

Optimum Shilajit is sourced from the Altai mountains and standardized for fulvic and humic acid content, the compounds most consistently tied to its documented research. See Optimum Shilajit.

See Optimum Shilajit